Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMIZE: Low-dose Tacrolimus and Everolimus in Elderly Renal Transplant Recipients
NCT03797196Phase 4Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jul 2019
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, open-label trial of everolimus in kidney transplant, sponsored by University Medical Center Groningen. Started Jul 2019; status: active, not recruiting.
02
Drugs
everolimus
03
Conditions
kidney transplant
Beyond the preview
Go deeper on NCT03797196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03797196.